| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Thilo Schroeder last filed a Form 4 in December 2024, as Director at SPRY. The filings on record cover 3 companies. From February 2020 to December 2024, the filings on record show 10 open-market purchases and 27 sales. Thilo Schroeder's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Thilo Schroeder a strong insider score of 80/100, based on 82 past trades. Over a 12-month horizon, 93.9% of those trades were profitable, with an average 12-month return of +43.0%.
At the last filing, the largest reported position was 760,869 shares of RVMD. Net of sales, the RVMD filings show accumulation of 4,025,662 shares.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 600 | $35.64 | $21,384.00 | - | -0.6% | -55.7% | |
| Apr 12, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 29,666 | $34.21 | $1,014,736.88 | -1.4% | +12.3% | -34.3% | |
| Apr 8, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 136,436 | $34.31 | $4,681,652.58 | -6.0% | -5.0% | -37.6% | |
| Apr 5, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 60,628 | $33.63 | $2,038,792.39 | -2.6% | -3.8% | -37.8% | |
| Mar 31, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 58,283 | $31.87 | $1,857,520.00 | -2.4% | +3.4% | -36.7% | |
| Mar 26, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 136,476 | $34.03 | $4,644,130.42 | -5.4% | -4.1% | -40.1% | |
| Dec 8, 2020 | SPRY Ars Pharmaceuticals, Inc. | Director | Buy | 238,096 | $21.00 | $5,000,016.00 | New | - | - |